Related Experiment Video

Updated: Oct 1, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

Inhibition of protein kinase C and proto-oncogene expression by crocetin in NIH/3T3 cells

C J Wang1, T C Cheng, J Y Liu

  • 1Institute of Biochemistry, Chung Shan Medical and Dental College, Taichung, Taiwan, Republic of China.

Molecular Carcinogenesis
|December 1, 1996
PubMed

Insights

Crocetin, a compound from Gardenia jasminoides, effectively inhibits tumor promotion by blocking protein kinase C (PKC) activity and reducing gene expression. This natural carotenoid shows promise in cancer research by interfering with key cellular signaling pathways.

Area of Science:

  • Pharmacology
  • Carotenoid Chemistry
  • Molecular Biology

Background:

  • Tumor promotion involves complex cellular signaling pathways.
  • 12-O-tetradecanoylphorbol-13-acetate (TPA) is a known tumor promoter.
  • Protein Kinase C (PKC) plays a crucial role in TPA-induced signaling.

Purpose of the Study:

  • To investigate the inhibitory effects of crocetin on TPA-induced tumor promotion.
  • To elucidate the molecular mechanisms underlying crocetin's anti-tumor promoting activity.

Main Methods:

  • Experiments were conducted using mouse fibroblast NIH/3T3 cells.
  • Assessed TPA-induced translocation and activity of Protein Kinase C (PKC).
  • Measured TPA-stimulated protein phosphorylation, PKC binding capacity, and gene expression (c-jun, c-fos).

Main Results:

  • Crocetin significantly inhibited TPA-induced PKC activity and translocation without affecting PKC protein levels.
  • Crocetin reduced TPA-stimulated cellular protein phosphorylation and PKC binding capacity.
  • Pretreatment with crocetin suppressed the expression of TPA-induced c-jun and c-fos genes.

Conclusions:

  • Crocetin acts as a potent inhibitor of TPA-mediated tumor promotion.
  • The mechanism involves the suppression of PKC activation and downstream signaling pathways.
  • Crocetin demonstrates potential as a chemopreventive agent against skin carcinogenesis.

More Related Videos

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...